Compounds > hydralazine
Page last updated: 2024-10-28

hydralazine and Cardiac Free Wall Rupture

hydralazine has been researched along with Cardiac Free Wall Rupture in 2 studies

Hydralazine: A direct-acting vasodilator that is used as an antihypertensive agent.
hydralazine : The 1-hydrazino derivative of phthalazine; a direct-acting vasodilator that is used as an antihypertensive agent.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wagner, GC1
Robinson, PH1
Phaneuf, DC1
Waters, DD1
Théroux, P1
Pelletier, G1
Mizgala, HF1

Other Studies

2 other studies available for hydralazine and Cardiac Free Wall Rupture

ArticleYear
The role of vasodilator therapy in the management of the patient with acute myocardial infarction.
    Primary care, 1981, Volume: 8, Issue:3

    Topics: Heart Failure; Heart Rupture; Hemodynamics; Humans; Hydralazine; Mitral Valve Insufficiency; Myocard

1981
Chronic oral vasodilator therapy to control heart failure in postinfarction ventricular septal defect.
    Catheterization and cardiovascular diagnosis, 1979, Volume: 5, Issue:3

    Topics: Administration, Oral; Aged; Drug Therapy, Combination; Female; Heart Failure; Heart Rupture; Heart S

1979